Cargando…
Estimating Progression Rates Across the Spectrum of Alzheimer’s Disease for Amyloid-Positive Individuals Using National Alzheimer’s Coordinating Center Data
INTRODUCTION: Published estimates of Alzheimer’s disease (AD) progression do not capture the full disease continuum. This study provides transition probabilities of individuals with amyloid-β (Aβ+) pathology across the disease continuum. METHODS: Patient-level longitudinal data from the National Alz...
Autores principales: | Potashman, Michele, Buessing, Marric, Levitchi Benea, Mihaela, Cummings, Jeffrey, Borson, Soo, Pemberton-Ross, Peter, Epstein, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571434/ https://www.ncbi.nlm.nih.gov/pubmed/34431074 http://dx.doi.org/10.1007/s40120-021-00272-1 |
Ejemplares similares
-
Economic and caregiver impact of Alzheimer’s disease across the disease spectrum: a cohort study
por: Dauphinot, Virginie, et al.
Publicado: (2022) -
Clinical Trial Endpoints and Their Clinical Meaningfulness in Early Stages of Alzheimer’s Disease
por: Cohen, S., et al.
Publicado: (2022) -
Estimation of impact of RPE65-mediated inherited retinal disease on quality of life and the potential benefits of gene therapy
por: Lloyd, Andrew, et al.
Publicado: (2019) -
Multiplex connectome changes across the alzheimer’s disease spectrum using gray matter and amyloid data
por: Canal-Garcia, Anna, et al.
Publicado: (2022) -
Clinicopathologic and (11)C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum
por: Murray, Melissa E., et al.
Publicado: (2015)